Eicos Sciences

San Mateo, United States Founded: 2016 • Age: 10 yrs
Develops Prostacyclin-based therapies for underserved medical conditions globally.

About Eicos Sciences

Eicos Sciences is a Healthcare company based in San Mateo (United States) founded in 2016. It develops Prostacyclin-based therapies for underserved medical conditions globally. It operates on a B2B model. The company has 9 employees. Its website eicossciences.com draws about 681 thousand monthly visits. Eicos Sciences offers products and services including Prostacyclin Analogues. Its focus areas include Biotechnology, Therapeutics and Prostacyclin Development. Its legal entity is CIVI BIOPHARMA, INC. Its competitors include Castle Creek Biosciences and LifeMax; 1 of its 2 listed competitors has raised funding.

Company details

Eicos Sciences is a biotechnology company focused on researching and developing Prostacyclin analogues, which act as vasodilators with antiplatelet and anti-inflammatory properties. The company targets debilitating conditions like frostbite, systemic sclerosis, and ECMO, where treatment options are scarce. Based in San Mateo, California, it operates as a subsidiary of CiVi Biopharma Holding Corp., aiming to improve patient outcomes through innovative science and therapeutic pipelines.

  • Headquarters San Mateo, United States
  • Employees 9
  • Sectors
    Healthcare
  • Website eicossciences.com
  • Legal Name Civi Biopharma, Inc.
Operational Areas
Key Metrics
  • Employee Count
    9

Products & Services of Eicos Sciences

Eicos Sciences offers a comprehensive portfolio of products and services, including Prostacyclin Analogues.

Prostacyclin Analogues
Biopharmaceuticals

Develops drugs targeting vasodilation and inflammation for rare diseases.

Competitors of Eicos Sciences

Eicos Sciences has 2 listed competitors in our database, 1 of them funded. They include Castle Creek Biosciences and LifeMax.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
castlecreekbio.com2018Exton, United States$192.8M41
Gene therapy platform for rare disease treatments is developed.
lifemaxlabs.com2014Redwood, United States
Develops innovative therapeutic solutions for Netherton syndrome treatment.
Premium access

Detailed competitors of Eicos Sciences

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Eicos Sciences

The website of Eicos Sciences (eicossciences.com) receives about 680.7K visits a month.

  • Monthly visits
    680.7K

    ▼ 6.7% vs previous month

Similar websites

Websites whose visitors overlap most with Eicos Sciences. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
falconebiz.com
100%
959.8K#63,970View details
tofler.in
97%
556K#105,509View details
zaubacorp.com
96%
4.9M#12,689View details
tracxn.com
92%
2.9M#16,597View details
indiafilings.com
90%
2.1M#29,959View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 40 similar websites and full traffic analytics for Eicos Sciences

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Cell Therapy

3 companies that operate in the same segment as Eicos Sciences (Cell Therapy) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
CAR T-cell and T-cell receptor immunotherapies for cancer are developed.
2013Seattle, Washington, United StatesUSD 316.67 M520
CAR-T and TIL immunotherapies for solid tumors are developed.
2018San Francisco, California, United StatesUSD 493 MUSD 36 K233
Smart surgical devices for spinal surgery are developed.
1997San Diego, California, United StatesUSD 54.1 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Eicos Sciences

Premium access

Complete news archive for Eicos Sciences

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Eicos Sciences

Eicos Sciences was founded in 2016.

Eicos Sciences is headquartered in San Mateo, United States. It is registered at San Mateo, California, United States.

Eicos Sciences has 9 employees.

Eicos Sciences is a biotechnology company focused on researching and developing Prostacyclin analogues, which act as vasodilators with antiplatelet and anti-inflammatory properties. The company targets debilitating conditions like frostbite, systemic sclerosis, and ECMO, where treatment options are scarce. Based in San Mateo, California, it operates as a subsidiary of CiVi Biopharma Holding Corp., aiming to improve patient outcomes through innovative science and therapeutic pipelines.

Eicos Sciences's top competitors include Castle Creek Biosciences and LifeMax.

Eicos Sciences offers Prostacyclin Analogues.

Eicos Sciences operates through Civi Biopharma, Inc..

The website of Eicos Sciences receives about 681 thousand visits a month.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available